Published: Guidance, quality standards and advice

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Type

Guidance programme

Showing 1 to 4 of 4

TitleReference numberPublishedLast updated
Carfilzomib with daratumumab and dexamethasone for treating relapsed or refractory multiple myeloma (terminated appraisal)TA841
Isatuximab with carfilzomib and dexamethasone for treating relapsed or refractory multiple myeloma (terminated appraisal)TA727
Carfilzomib with dexamethasone and lenalidomide for previously treated multiple myelomaTA695
Carfilzomib for previously treated multiple myelomaTA657

Results per page

  1. 10
  2. 25
  3. 50
  4. All